Cargando…
Evaluation of the immunogenicity and efficacy of a chimeric OMP25–OMP31 antigen in BALB/c mice
Brucellosis is a zoonotic disease causes by Brucella bacteria. So far, there is not any efficient treatment for this infectious disease in animals, although subunit vaccines can be a safe alternative. To this aim, we have designed a new chimeric OMP25‐OMP31 antigen formulated in Chitosan nanoparticl...
Autor principal: | Mohammadi, Yahya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8464292/ https://www.ncbi.nlm.nih.gov/pubmed/34057317 http://dx.doi.org/10.1002/vms3.537 |
Ejemplares similares
-
Immunogenicity evaluation of plasmids encoding Brucella melitensis Omp25 and Omp31 antigens in BALB/c mice
por: Shojaei, Moslem, et al.
Publicado: (2018) -
In vivo immunogenicity assessment and vaccine efficacy evaluation of a chimeric tandem repeat of epitopic region of OMP31 antigen fused to interleukin 2 (IL-2) against Brucella melitensis in BALB/c mice
por: Nazifi, Narges, et al.
Publicado: (2019) -
A hybrid protein containing MSP1a repeats and Omp7, Omp8 and Omp9 epitopes protect immunized BALB/c mice against anaplasmosis
por: Cangussu, Alex Sander R., et al.
Publicado: (2018) -
Comparison of BP26, Omp25 and Omp31 and a Multiepitope-Based Fusion Protein in the Serological Detection of Canine Brucellosis
por: Yao, Meixue, et al.
Publicado: (2022) -
The Immunogenicity of OMP31 Peptides and Its Protection Against Brucella melitensis Infection in Mice
por: Zhang, Fengbo, et al.
Publicado: (2019)